Well it looks like the previous story is coming to a head a bit sooner than 3 months.
The UK CompCom delivered its findings today:
Pvt Hospitals will have to sell off some of their hospitals etc.essentially anti competitive behaviour will stop. The sell-off will affect the OPCO division of BMI/GHG/Netcare ---to what extend the share price will tell us.I expect lengthy appeals however. The same picture will unfold in SA over the next year with the SA CompCom investigation into healthcare---only the collution here by private hospitals the will be much more substantial. wonder how many whistleblowers there are lurking.
"the report is critical of providers such as HCA International and BMI Healthcare, stating that: “HCA charges significantly higher prices to insurers than other operators, even allowing for higher costs in London. Of the other hospital operators, BMI has consistently charged the highest price to insurers in recent years… BMI, HCA and Spire have, during the period under review, been earning returns substantially and persistently in excess of the cost of capital. Ramsay did so for some of the period.”
Stephen Collier, chief executive of BMI Healthcare, said in a statement: “We reject absolutely any assertion that BMI Healthcare and its hospitals exercise market power or that we make excess profits at the expense of patients.”
The report does not name the 20 hospitals recommended for divestment, with a further announcement expected this Friday, but the report cites BMI Healthcare, Spire Healthcare and HCA International as operators that benefit from dominance in certain markets.
The report states that divestment of these assets should be to both new entrants and existing players, and it is expected rival groups such as Ramsay Healthcare, Nuffield Health, Circle Health and Care UK will look to carve up the hospitals between them.
It is possible that an overseas buyer could look to acquire all 20 of the assets, however the hospitals are unlikely to provide the scale and infrastructure required for a major overseas investor.
Other remedies suggested included measures to prevent incumbents in areas with just one or two hospitals from expanding and deterring entry by partnering with NHS hospitals to operate Private Patient Units.
The CC also recommends preventing hospital operators from offering to consultants any arrangements, in cash or kind, which create incentives for consultants to refer patients to or treat them at its hospitals.
The report also considers measures to prevent tying and bundling—where a hospital operator seeks to use its position in local areas as leverage in its negotiations with insurers—by stopping hospital operators responding to a loss of business or reduction in price in one area by raising charges in another.
CC chairman and chairman of the Private Healthcare Inquiry Group, Roger Witcomb said: “The lack of competition in the healthcare market at a local level means that most private patients are paying more than they should either for private medical insurance or for self-funded treatment. The lack of available and comparable information, often less than is available to NHS patients, also makes informed choices—which could help drive competition—for these patients difficult.”he report is critical of providers such as HCA International and BMI Healthcare, stating that: “HCA charges significantly higher prices to insurers than other operators, even allowing for higher costs in London. Of the other hospital operators, BMI has consistently charged the highest price to insurers in recent years… BMI, HCA and Spire have, during the period under review, been earning returns substantially and persistently in excess of the cost of capital. Ramsay did so for some of the period.”
Stephen Collier, chief executive of BMI Healthcare, said in a statement: “We reject absolutely any assertion that BMI Healthcare and its hospitals exercise market power or that we make excess profits at the expense of patients.”
The report does not name the 20 hospitals recommended for divestment, with a further announcement expected this Friday, but the report cites BMI Healthcare, Spire Healthcare and HCA International as operators that benefit from dominance in certain markets.
The report states that divestment of these assets should be to both new entrants and existing players, and it is expected rival groups such as Ramsay Healthcare, Nuffield Health, Circle Health and Care UK will look to carve up the hospitals between them.
It is possible that an overseas buyer could look to acquire all 20 of the assets, however the hospitals are unlikely to provide the scale and infrastructure required for a major overseas investor.
Other remedies suggested included measures to prevent incumbents in areas with just one or two hospitals from expanding and deterring entry by partnering with NHS hospitals to operate Private Patient Units.
The CC also recommends preventing hospital operators from offering to consultants any arrangements, in cash or kind, which create incentives for consultants to refer patients to or treat them at its hospitals.
The report also considers measures to prevent tying and bundling—where a hospital operator seeks to use its position in local areas as leverage in its negotiations with insurers—by stopping hospital operators responding to a loss of business or reduction in price in one area by raising charges in another.
CC chairman and chairman of the Private Healthcare Inquiry Group, Roger Witcomb said: “The lack of competition in the healthcare market at a local level means that most private patients are paying more than they should either for private medical insurance or for self-funded treatment. The lack of available and comparable information, often less than is available to NHS patients, also makes informed choices—which could help drive competition—for these patients difficult.”he report is critical of providers such as HCA International and BMI Healthcare, stating that: “HCA charges significantly higher prices to insurers than other operators, even allowing for higher costs in London. Of the other hospital operators, BMI has consistently charged the highest price to insurers in recent years… BMI, HCA and Spire have, during the period under review, been earning returns substantially and persistently in excess of the cost of capital. Ramsay did so for some of the period.”
Stephen Collier, chief executive of BMI Healthcare, said in a statement: “We reject absolutely any assertion that BMI Healthcare and its hospitals exercise market power or that we make excess profits at the expense of patients.”
The report does not name the 20 hospitals recommended for divestment, with a further announcement expected this Friday, but the report cites BMI Healthcare, Spire Healthcare and HCA International as operators that benefit from dominance in certain markets.
The report states that divestment of these assets should be to both new entrants and existing players, and it is expected rival groups such as Ramsay Healthcare, Nuffield Health, Circle Health and Care UK will look to carve up the hospitals between them.
It is possible that an overseas buyer could look to acquire all 20 of the assets, however the hospitals are unlikely to provide the scale and infrastructure required for a major overseas investor.
Other remedies suggested included measures to prevent incumbents in areas with just one or two hospitals from expanding and deterring entry by partnering with NHS hospitals to operate Private Patient Units.
The CC also recommends preventing hospital operators from offering to consultants any arrangements, in cash or kind, which create incentives for consultants to refer patients to or treat them at its hospitals.
The report also considers measures to prevent tying and bundling—where a hospital operator seeks to use its position in local areas as leverage in its negotiations with insurers—by stopping hospital operators responding to a loss of business or reduction in price in one area by raising charges in another.
CC chairman and chairman of the Private Healthcare Inquiry Group, Roger Witcomb said: “The lack of competition in the healthcare market at a local level means that most private patients are paying more than they should either for private medical insurance or for self-funded treatment. The lack of available and comparable information, often less than is available to NHS patients, also makes informed choices—which could help drive competition—for these patients difficult.”
http://www.healthinv...CookieSupport=1
Secondly the PROPCO division of GHG/BMI/Netcare is still in the process of securing refinancing. At least one of the senior lenders ,Barclays , is not enthusiastic about the proposed refinancing and wants a measured sale of some of the PROPCO properties(the private hospital properties/buildings) The propco problems are supposedly non-recource to the opco operations. However it may also be that Barclays is worried about the ability of the opco of the UK Netcare/GHG/BMI to service the rentals in view of the findings of the CompCom
'General Healthcare Lenders Can Vote on Debt Deal, Judge Rules
By Jeremy Hodges - Aug 23, 2013 4:17 PM GMT+0200
Barclays Plc (BARC) can vote on a proposed restructuring of about 660 million pounds ($1 billion) of securitized debt linked to General Healthcare Group Ltd., a London judge ruled.
Barclays is among a group of senior lenders to General Healthcare who had sought guidance on their voting rights, Judge Peter Smith said in his ruling today. Loans underlying two special purpose vehicles are due to be repaid in October, and if a restructuring isn’t arranged “there is likely to be a security shortfall,” a Citigroup Inc. unit acting as trustee to the debt said in documents from a court hearing August 14.
Junior lenders to General Healthcare, whose largest shareholder is South Africa-based Netcare Ltd. (NTC) and runs 65 private hospitals in the U.K., are seeking to extend the date of repayment for about 1.5 billion pounds of debt maturing in October.
Barclays holds 231 million pounds of Class A notes issued by Theatre (Hospitals) No. 1 Plc, and 57 million pounds in Class B notes sold by Theatre (Hospitals) No. 2 Plc, according to the judgment. Rabobank International has 154 million pounds in Class A Notes of the Theatre 2 bonds, which are subject to a swap agreement with Barclays.
Citicorp Trustee Company Ltd. can’t proceed with a restructuring without approval from Barclays and Rabobank, it said in legal documents."
http://www.bloomberg...udge-rules.html
I find all this very fascinating and complex , perhaps Shevell was very clever when he cashed in and jumped the boat
Another story is that Mediclin wants to sell off chunks of its priate hospitals to the specialists working in them--after they recently registered each of them in a seperate company. The profits have been made , the compcom is coming , lets decrease our exposure , I think , is the background
We will see